Saudi Arabia Pharmaceuticals Market to Accelerate at a CAGR of Around 7.93% During 2025-30

• Overview
• Table of Content
• Research Methodology
• Download Free Sample

Saudi Arabia Pharmaceuticals Market Overview, Trends, Size and Forecast: 2025-2030

The Saudi Arabia Pharmaceuticals Market size was valued at around USD 12.37 billion in 2025 and is projected to reach USD 18.12 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.93% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. The market growth is driven by several growth factors, including the active support of the Saudi government, by investing significantly in the expansion of the pharmaceutical manufacturing industry in the country through various policies, like Vision 2030, Saudi Industrial Development, Industry 4.0, and Made in Saudi Arabia Initiative, and the adoption of advanced medications, including biologics, biosimilars, and many more.

One of the major growth factors is the surging health issues, like diabetes, cancer, cardiovascular diseases, respiratory diseases, and infectious diseases, which are accelerating the demand for particular drugs and treatment products, thus increasing the growth of the pharmaceutical industry. Additionally, the Saudi government is actively supporting this market through heavy investments to improve the pharmaceutical manufacturing industry by building new manufacturing plants and factories to avoid dependence on imports. These efforts are contributing to the potential growth of the market. Moreover, the R&D has recently gained traction in Saudi Arabia, backed by the rising investments through public and private partnerships, which have led to the adoption of advanced pharmaceutical products, including biologics and biosimilars in the country, as these are more effective and target specific, providing better treatments, thus uplifting the market growth.

Furthermore, the retail pharmacies are spread widely across the country, having a wide range of products, including drugs, vaccines, dietary supplements, cosmetics, etc., which is grabbing the attention of millions of people and increasing the substantial market growth. However, the shortage of manufacturing units in the country leads to a high dependence on imports of pharmaceutical products, thus restraining the market growth, further states the research report, “Saudi Arabia Pharmaceuticals Market Analysis, 2025.”

Saudi Arabia Pharmaceuticals Market Segmentation Insights:

Prescription Drugs Witness Massive Market Demand

Based on the product type, the market is further segmented into Prescription Drugs, Over-the-counter Drugs, and Biologics & Biosimilars. Out of these, prescription drugs are leading the market, accounting for around 60% market share. The rising burden of various diseases, including infectious and non-infectious diseases, in the country causes their high demand. As per the International Diabetes Federation (IDF) (2024), millions of adults are living with diabetes in the country, whereas cardiovascular diseases cause major deaths in the country, which is about 47% of all the deaths caused in Saudi Arabia. Such a rising burden increases the demand for prescription drugs in the country, thus contributing to their dominance in this market.

Additionally, Saudi Arabia has witnessed a surge in the aging population in Saudi Arabia, which is growing the demand for the prescription drugs segment, due to the high vulnerability of these diseases, which increases the demand for these drugs.

Hospital Pharmacies Generating Maximum Market Revenue

Among these, the hospital pharmacies hold the largest market share of more than 42%. The dominance is due to the widespread presence of hospitals across Saudi Arabia, which is more than 498 in number, with thousands of hospital pharmacies. These are rapidly growing as hospitals deal with a large number of patients daily, which increases the probability of these patients purchasing medications from the nearest spot, which is the hospital pharmacy itself, thus contributing to the dominance of these in the market. Additionally, the majority of the medications are prescription drugs only, which are only written in hospitals during visits, so it makes it easier for the patients to purchase the drugs from the nearest distribution channel, that is, the hospital pharmacies, thus generating maximum market revenue. Moreover, hospital pharmacies are equipped with healthcare services such as diagnostics and treatment, making them convenient for patients to get prescribed medicines quickly, improving treatment adherence. Hence, this distribution channel is the most preferred by the end-users.

Top Companies in the Saudi Arabia Pharmaceuticals Market

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading pharmaceuticals companies in the saudi arabian market, including Pfizer, Sanofi, Novartis, SPIMACO, Tabuk Pharmaceuticals, Jamjoom Pharma, Riyadh Pharma, GlaxoSmithKline, Hikma Pharmaceuticals, AstraZeneca, and Others, are looking forward to increase their market size & share.

Key Questions Answered in the Research Report

1. What is the scope, size, value, and forecast of the Saudi Arabia Pharmaceuticals Market?
2. What is the volume and share of each segment in the Saudi Arabia Pharmaceuticals Market?
3. What are the key trends shaping the Saudi Arabia Pharmaceuticals Market from 2025 to 2030?
4. What growth factors and risks impact the Saudi Arabia Pharmaceuticals Market?
5. What are the main challenges faced by players in the Saudi Arabia Pharmaceuticals Market?
6. What are the top opportunities in the Saudi Arabia Pharmaceuticals Market?
7. What does competitive analysis reveal about the Saudi Arabia Pharmaceuticals Market landscape?
8. Who are the key players and companies leading the Saudi Arabia Pharmaceuticals Market?
9. What innovations are transforming the future dynamics of the Saudi Arabia Pharmaceuticals Market?
10. How are partnerships and collaborations driving the Saudi Arabia Pharmaceuticals Market growth?
11. How does the Saudi Arabia Pharmaceuticals Market differ based on geography and segments?